HP
TMDX icon

Harbourvest Partners’s Transmedics TMDX Stock Holding History

Harbourvest Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-116,123
Closed -$2.23M – 74
2021
Q4 		$2.23M Buy
+116,123
New +$2.91M 0.28% 32
2020
Q1 		– Sell
-11,931
Closed -$227K – 40
2019
Q4 		$227K Buy
+11,931
New +$219K 0.09% 31

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Harbourvest Partners's TMDX Position: Q1 2022 in Review

Harbourvest Partners sold out of Transmedics (TMDX) in Q1 2022, closing a stake of 116,123 shares — an estimated $2.23M sold.

Harbourvest Partners first reported a position in TMDX in Q4 2019 and held it in 2 quarters. The position peaked at $2.23M in Q4 2021. 110 funds tracked by Wall St. Rank hold TMDX as of Q1 2022.

  • Harbourvest Partners reported no remaining Transmedics position as of Q1 2022 after selling out during the quarter.
  • Harbourvest Partners sold 116,123 Transmedics shares in Q1 2022, an estimated $2.23M.
  • Harbourvest Partners first reported a position in Transmedics in Q4 2019 and held it in 2 quarters.
  • Harbourvest Partners's Transmedics position peaked at $2.23M in Q4 2021.
  • 110 funds tracked by Wall St. Rank held Transmedics as of Q1 2022.

Based on Harbourvest Partners's 13F filing for Q1 2022, filed 13 May 2022.